The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

We recently compiled a list of the 10 AI News You Should Not Miss. In this article, we are going to take a look at where ...

Clinical trials of the first drugs designed with the help of artificial intelligence could commence this year, Google ...

Google's DeepMind spinoff Isomorphic Labs expects clinical trials of drugs designed using AI to start late this year.

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...

An Alphabet-backed startup is poised to begin clinical trials of its first artificial intelligence-designed drug by year-end.

Alphabet’s artificial intelligence start-up Isomorphic Labs has made a splash at the start of the JP Morgan Healthcare conference this week, announcing its first pharma partnerships with Eli ...

Alphabet’s Google DeepMind and its sister company Isomorphic Labs have created a new AI model that they say can help predict both the structure and interaction of most molecules involved in ...

Among the most important aspects of this story is AlphaFold, the artificial intelligence and foundation model platform developed by Google DeepMind and Isomorphic Labs, both Alphabet companies.

The pharma giant is partnering with software firms to imagine new drugs, find targets, and design clinical trials ...

Isomorphic Labs launches into an already well-populated drug discovery category, with many large drugmakers exploring the technology along with a host of specialist players like Exscientia ...

Google DeepMind spinoff Isomorphic Labs expects research of drugs it designed using artificial intelligence will begin this ...